Scalper1 News
Edwards Lifesciences (EW) late Tuesday beat second-quarter earnings estimates, keeping alive a streak that has lasted more than two years. The heart-valve maker said second-quarter earnings per share minus items rose 28% from the year-earlier quarter to $1.13. Edwards has beaten estimates from analysts polled by Thomson Reuters each quarter going back to at least 2013. For the second quarter, analysts on average had forecast earnings of just $1.05 Scalper1 News
Scalper1 News